Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07241039 |
| Title | A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START Midwest /ID# 272505 | RECRUITING | Grand Rapids | Michigan | 49546 | United States | Details |
| Carolina BioOncology Institute /ID# 272380 | RECRUITING | Huntersville | North Carolina | 28078 | United States | Details |
| Next Oncology - Irving /ID# 276659 | RECRUITING | Irving | Texas | 75039 | United States | Details |
| Kansai Medical University Hospital /ID# 276586 | RECRUITING | Hirakata-shi | Osaka | 573-1191 | Japan | Details |